Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Novo Nordisk's (NVO) third-quarter earnings were solid enough to soothe investor jitters and turn the market's attention toward upcoming trial results for a potentially game-changing new weight-loss ...

Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...

Q3 2024 Earnings Call Transcript November 6, 2024 Evotec SE misses on earnings expectations. Reported EPS is $-0.12 EPS, ...

Restaurant Brands International Inc. (T.QSR) (Q3) EPS of $1.30, compared to $1.18 in the prior-year quarter. Novo Nordisk (NYSE: NVO) (Q3) EPS of $3.08, compared to $2.99 in the prior-year quarter.

In corporate news, Novo Nordisk A/S (NOVOB.C.DX) surged over +7% after the pharmaceutical giant reported better-than-expected Q3 sales of its popular Wegovy weight-loss drug and narrowed its full-year ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

In the global pharmaceutical industry, there were eight M&A deals announced in Q3 2024, worth a total value of $1.3bn, according to GlobalData's Deals Database.

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

Bagsværd, Denmark, 7 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated ...

Phuket’s tropical charm has once again worked its magic, landing it among Asia’s Top 10 island destinations, as revealed by the esteemed Condé Nast Traveler Readers’ Choice Awards. UK tabloid Daily ...